Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 15569865)

Published in Stroke on November 29, 2004

Authors

David M Kent1, Lori Lyn Price, Peter Ringleb, Michael D Hill, Harry P Selker

Author Affiliations

1: Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, 750 Washington Street, #63, Boston, MA, 02111, USA. dkent1@tufts-nemc.org

Articles citing this

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63

Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials. Stroke (2014) 2.19

Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.76

Sex differences in stroke. Cerebrovasc Dis (2008) 1.24

Sex differences in minocycline-induced neuroprotection after experimental stroke. J Cereb Blood Flow Metab (2009) 1.18

Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis (2010) 1.12

Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry (2006) 1.09

Sexual dimorphism in ischemic stroke: lessons from the laboratory. Womens Health (Lond Engl) (2011) 1.00

Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99

Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke. Neurosci Lett (2010) 0.96

Sex-specific responses to stroke. Future Neurol (2010) 0.96

Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke (2012) 0.89

PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol (2013) 0.87

Differences in stroke outcome based on sex. Neurology (2010) 0.85

A rat's whiskers point the way toward a novel stimulus-dependent, protective stroke therapy. Neuroscientist (2012) 0.82

Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA. Transl Stroke Res (2015) 0.81

Disability status at 1 month is a reliable proxy for final ischemic stroke outcome. Neurology (2010) 0.81

Exploring gender distribution in patients with acute stroke: A multi-national approach. J Res Med Sci (2013) 0.81

Effects of Early Post-Ischemic Reperfusion and tPA on Cerebrovascular Function and Nitrosative Stress in Female Rats. Transl Stroke Res (2016) 0.80

Impact of sex in stroke thrombolysis: a coarsened exact matching study. BMC Neurol (2015) 0.80

Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries. PLoS One (2013) 0.79

Sex differences in stroke therapies. J Neurosci Res (2017) 0.79

U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats. J Cereb Blood Flow Metab (2014) 0.79

Emergency department arrival times, treatment, and functional recovery in women with acute ischemic stroke. J Womens Health (Larchmt) (2010) 0.78

Knockout of ho-1 protects the striatum from ferrous iron-induced injury in a male-specific manner in mice. Sci Rep (2016) 0.78

The Importance of Considering Sex Differences in Translational Stroke Research. Transl Stroke Res (2016) 0.78

Field Synopsis of the Role of Sex in Stroke Prediction Models. J Am Heart Assoc (2016) 0.77

Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients? Cerebrovasc Dis (2008) 0.76

Knowledge of stroke a study from a sex perspective. BMC Res Notes (2015) 0.75

Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke. Stroke (2005) 0.75

Does the sex of acute stroke patients influence the effectiveness of rt-PA? BMC Neurol (2014) 0.75

Stroke treatment and prevention are not the same in men and women. Medscape J Med (2008) 0.75

Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke. Stroke Res Treat (2014) 0.75

Under-representation of women in stroke randomized controlled trials: inadvertent selection bias leading to suboptimal conclusions. Ther Adv Neurol Disord (2017) 0.75

Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample. Front Neurol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA (2005) 9.61

Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68

Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32

Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA (2013) 5.05

Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82

Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci (2004) 4.81

Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke (2005) 4.07

Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91

Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol (2007) 3.72

Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA (2002) 3.65

Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06

Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology (2012) 3.02

Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94

Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88

Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke (2010) 2.79

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke (2006) 2.77

Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74

Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med (2010) 2.67

Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke (2012) 2.64

What causes disability after transient ischemic attack and minor stroke?: Results from the CT and MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study. Stroke (2012) 2.53

The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke (2006) 2.43

Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke (2005) 2.27

Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol (2010) 2.12

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase. Am J Med (2002) 2.12

Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome. Stroke (2013) 2.11

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J (2008) 2.09

Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke (2005) 2.08

Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke (2003) 2.05

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke (2006) 2.04

Emergency physicians' fear of malpractice in evaluating patients with possible acute cardiac ischemia. Ann Emerg Med (2005) 2.02

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01

Escalating levels of access to in-hospital care and stroke mortality. Stroke (2008) 1.97

Intravenous thrombolysis for acute ischaemic stroke in young adult patients. Can J Neurol Sci (2009) 1.95

CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke (2012) 1.92

Atypical presentations among Medicare beneficiaries with unstable angina pectoris. Am J Cardiol (2002) 1.92

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91

Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience. Age Ageing (2004) 1.90

When to expect negative diffusion-weighted images in stroke and transient ischemic attack. Stroke (2008) 1.88

From suspicion of physical child abuse to reporting: primary care clinician decision-making. Pediatrics (2008) 1.88

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85

Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina (2010) 1.82

Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients? Stroke (2008) 1.81

Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78

High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol (2013) 1.75

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc Dis (2010) 1.74

The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification. Neurology (2008) 1.73

Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71

Volume-outcome relationship for coronary artery bypass grafting in an era of decreasing volume. Arch Surg (2008) 1.70

A smartphone client-server teleradiology system for primary diagnosis of acute stroke. J Med Internet Res (2011) 1.67

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol (2006) 1.67

Stroke: the Elixhauser Index for comorbidity adjustment of in-hospital case fatality. Neurology (2008) 1.67

Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol (2005) 1.67

Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2009) 1.65

Weather, Chinook, and stroke occurrence. Stroke (2002) 1.64

Complications in MS patients after CCSVI procedures abroad (Calgary, AB). Can J Neurol Sci (2011) 1.62

Impact of a stroke unit on length of hospital stay and in-hospital case fatality. Stroke (2008) 1.59

TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci (2005) 1.58

Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation (2007) 1.58

Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes. Stroke (2010) 1.58

Clinicians' description of factors influencing their reporting of suspected child abuse: report of the Child Abuse Reporting Experience Study Research Group. Pediatrics (2008) 1.57

Neighborhood income and stroke care and outcomes. Neurology (2012) 1.56

CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke (2007) 1.55

Stroke- on- Awakening: Safety of CT-CTA Based Selection for Reperfusion Therapy. Can J Neurol Sci (2014) 1.55

How accurate is ICD coding for epilepsy? Epilepsia (2009) 1.54

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry (2006) 1.52

Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy. Stroke (2008) 1.52

Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke (2008) 1.51

Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke (2008) 1.51

Outcomes among 3.5 million newly diagnosed hypertensive Canadians. Can J Cardiol (2013) 1.50

The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry (2006) 1.50

Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis (2003) 1.49

Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism. Circulation (2013) 1.49

Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke (2005) 1.48

Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke. Cerebrovasc Dis (2012) 1.48

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke (2006) 1.48

Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke (2006) 1.47

A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Hepatology (2004) 1.47

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46

Patients with transient ischemic attack or minor stroke should be admitted to hospital: for. Stroke (2006) 1.45

Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Radiother Oncol (2013) 1.45

Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci (2009) 1.45

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2010) 1.44

An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke (2008) 1.43

Effects of alkali supplementation and vitamin D insufficiency on rat skeletal muscle. Endocrine (2013) 1.43

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol (2009) 1.42

Autoregulation of cerebral blood flow is preserved in primary intracerebral hemorrhage. Stroke (2013) 1.41

Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke (2004) 1.41

Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg? Stroke (2011) 1.41

Evaluation of the shock index in dogs presenting as emergencies. J Vet Emerg Crit Care (San Antonio) (2013) 1.39

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2011) 1.38

Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke (2014) 1.38

Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care (2009) 1.37

Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women. Neurobiol Aging (2008) 1.37

Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke (2003) 1.36

Do all age groups benefit from organized inpatient stroke care? Stroke (2009) 1.36